Mutagenetix > Incidental Mutation

Incidental Mutation 'R8258:Dusp9'

640107

Institutional Source

Beutler Lab

Gene Symbol

Dusp9

Ensembl Gene

ENSMUSG00000031383

Gene Name

dual specificity phosphatase 9

Synonyms

Mpk4, Pyst3

MMRRC Submission

067684-MU

Accession Numbers

Essential gene?

Probably non essential (E-score: 0.191) question?

Stock #

R8258 (G1)

Quality Score

187.46

Status

Validated

Chromosome

Chromosomal Location

72683025-72687120 bp(+) (GRCm39)

Type of Mutation

small deletion (16 aa in frame mutation)

DNA Base Change (assembly)

TAAAGCGGAGGCCAAAGCGGAGGCCAAAGCGGAGGCTAAAGCGGAGGCCAAAGCGGAGGCCAAAGCGGAGGCCAAAGCGGAGGCTAAAGCGGAGGCCAAAGCGGAGGCCAAAG to TAAAGCGGAGGCCAAAGCGGAGGCCAAAGCGGAGGCTAAAGCGGAGGCCAAAGCGGAGGCCAAAG at 72684217 bp (GRCm39)

Zygosity

Heterozygous

Amino Acid Change

Ref Sequence

ENSEMBL: ENSMUSP00000019701 (fasta)

Gene Model

predicted gene model for transcript(s): [ENSMUST00000019701]

AlphaFold

Q7TNL7

Predicted Effect

probably benign
Transcript: ENSMUST00000019701

SMART Domains

Protein: ENSMUSP00000019701
Gene: ENSMUSG00000031383

Domain	Start	End	E-Value	Type
RHOD	8	204	2.51e-9	SMART
low complexity region	236	249	N/A	INTRINSIC
DSPc	271	411	6.09e-67	SMART

Meta Mutation Damage Score

0.0846

Coding Region Coverage

1x: 100.0%
3x: 99.9%
10x: 99.7%
20x: 99.2%

Validation Efficiency

100% (55/55)

MGI Phenotype

FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which is associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene product shows selectivity for members of the ERK family of MAP kinases and is localized to the cytoplasm and nucleus. Aberrant expression of this gene is associated with type 2 diabetes and cancer progression in several cell types. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
PHENOTYPE: Hemizygous null male and heterozygous null female mice display embryonic lethality during organogenesis with abnormal placental labyrinth morphology when the allele is maternally inherited. Tetraploid rescue produces viable heterozygous and hemizygous mice. [provided by MGI curators]

Allele List at MGI

Other mutations in this stock

Total: 54 list
Gene	Ref	Var	Chr/Loc	Mutation	Predicted Effect	Zygosity
Abcg5	T	G	17: 84,983,523 (GRCm39)	T144P	possibly damaging	Het
Adhfe1	A	G	1: 9,628,417 (GRCm39)	N263S	probably null	Het
Aebp2	A	T	6: 140,583,453 (GRCm39)	Q309L	possibly damaging	Het
Akap7	A	G	10: 25,047,054 (GRCm39)	Y281H	probably damaging	Het
Atg2a	G	A	19: 6,299,859 (GRCm39)	A588T	probably damaging	Het
Calcoco1	T	C	15: 102,624,228 (GRCm39)	D236G	probably damaging	Het
Camsap2	A	T	1: 136,208,077 (GRCm39)	D470E	probably benign	Het
Capn8	G	T	1: 182,392,698 (GRCm39)	V25L	probably benign	Het
Card10	A	G	15: 78,660,884 (GRCm39)	V1041A	probably damaging	Het
Ccr1	T	A	9: 123,764,119 (GRCm39)	H137L	probably damaging	Het
Cdh23	A	T	10: 60,151,435 (GRCm39)	D2483E	probably damaging	Het
Chd2	G	T	7: 73,085,532 (GRCm39)	Q1701K	probably benign	Het
Cimap2	C	T	4: 106,448,859 (GRCm39)	G400S	probably damaging	Het
Ckmt2	T	A	13: 92,007,335 (GRCm39)	R286S	probably damaging	Het
Cyp27a1	A	T	1: 74,771,214 (GRCm39)	D133V	probably benign	Het
Eml1	A	T	12: 108,476,458 (GRCm39)	I283F	probably damaging	Het
Fat3	A	G	9: 15,901,887 (GRCm39)	V3046A	possibly damaging	Het
Fbxw20	A	G	9: 109,063,763 (GRCm39)	V3A	probably benign	Het
Fcgr2b	A	G	1: 170,795,702 (GRCm39)	S76P	possibly damaging	Het
Fgg	C	T	3: 82,917,477 (GRCm39)	Q169*	probably null	Het
Ggt5	G	A	10: 75,450,666 (GRCm39)	V558I	probably benign	Het
Gm4779	G	C	X: 100,837,390 (GRCm39)	T171S	possibly damaging	Het
Incenp	A	G	19: 9,870,993 (GRCm39)	L212P	unknown	Het
Incenp	G	C	19: 9,871,005 (GRCm39)	T208R	unknown	Het
Mctp1	T	A	13: 76,949,666 (GRCm39)		probably null	Het
Megf8	T	C	7: 25,057,848 (GRCm39)	M2095T	probably benign	Het
Mroh2b	G	A	15: 4,941,391 (GRCm39)	V308I	probably benign	Het
Muc1	T	A	3: 89,139,341 (GRCm39)	H580Q	probably damaging	Het
Naip6	A	T	13: 100,452,920 (GRCm39)	M47K	probably benign	Het
Nrxn1	C	A	17: 90,471,249 (GRCm39)	R1260L	probably damaging	Het
Nynrin	A	G	14: 56,100,815 (GRCm39)	I202V	possibly damaging	Het
Or14j7	T	C	17: 38,234,847 (GRCm39)	L130P	probably damaging	Het
Or5ac17	T	C	16: 59,036,458 (GRCm39)	I173V	probably benign	Het
Or5b98	T	C	19: 12,931,727 (GRCm39)	M258T	possibly damaging	Het
Pard3	G	A	8: 128,098,021 (GRCm39)	W354*	probably null	Het
Pcnx3	C	T	19: 5,715,412 (GRCm39)	G1946E	probably damaging	Het
Peak1	A	G	9: 56,166,677 (GRCm39)	V417A	probably damaging	Het
Prune2	A	G	19: 17,189,672 (GRCm39)	R3052G	unknown	Het
Prx	T	C	7: 27,218,808 (GRCm39)	L1242P	probably damaging	Het
Pxylp1	A	G	9: 96,707,633 (GRCm39)	I183T	probably benign	Het
Ranbp2	A	G	10: 58,291,755 (GRCm39)	E254G	probably benign	Het
Rhot2	C	A	17: 26,058,864 (GRCm39)	R512L	probably benign	Het
Rpa1	T	C	11: 75,193,550 (GRCm39)	N594D	probably benign	Het
Rxfp2	T	A	5: 149,983,365 (GRCm39)	I300K	probably damaging	Het
Scarf1	T	A	11: 75,414,689 (GRCm39)	S486T	probably damaging	Het
Slc24a4	T	C	12: 102,220,928 (GRCm39)	V455A	probably damaging	Het
Slitrk1	A	G	14: 109,148,653 (GRCm39)	V686A	probably benign	Het
Spata31e2	T	C	1: 26,721,562 (GRCm39)	E1206G	probably benign	Het
Syne2	C	A	12: 75,996,143 (GRCm39)	Q2228K	possibly damaging	Het
Tenm4	G	A	7: 96,517,198 (GRCm39)	G1430S	probably damaging	Het
Tlr12	C	A	4: 128,511,492 (GRCm39)	A253S	probably benign	Het
Trpm1	G	A	7: 63,918,777 (GRCm39)	A1590T	probably benign	Het
Vmn1r184	T	A	7: 25,966,686 (GRCm39)	M144K	probably benign	Het
Wee2	A	G	6: 40,421,114 (GRCm39)	D68G	probably benign	Het

Other mutations in Dusp9

Allele	Source	Chr	Coord	Type	Predicted Effect	PPH Score
IGL02968:Dusp9	APN	X	72,685,039 (GRCm39)	missense	probably benign	0.00
R4654:Dusp9	UTSW	X	72,684,378 (GRCm39)	missense	probably benign	0.31
R7075:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
R7389:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
R7412:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
R7930:Dusp9	UTSW	X	72,684,128 (GRCm39)	small deletion	probably benign
R7958:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
R8228:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
R8334:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
R8970:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
R9010:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
R9140:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
R9173:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
R9241:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
R9359:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
R9373:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
R9474:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
R9548:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
R9780:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
RF030:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign
RF039:Dusp9	UTSW	X	72,684,217 (GRCm39)	small deletion	probably benign

Predicted Primers

PCR Primer
(F):5'- AGAGTCTGAGTCGGTCATGC -3'
(R):5'- GATCTTTTCTCCTGACCTGAGG -3'

Sequencing Primer
(F):5'- AGCTGTATGAGTCGGCGC -3'
(R):5'- TCCAGAGTGCTCTCTCAGG -3'

Posted On

2020-07-28